Walk down the hall at Boston Scientific sites around the world, and you’ll see these words displayed on the wall, surrounded by signatures: “I improve the quality of patient care and all things Boston Scientific.”
It’s a statement our employees stand by, so much so that they’re willing to put their names on it.
It’s also an expectation that Boston Scientific has for every person who works at the company, no matter their role, region or career level.
And it’s a commitment to quality that we renew each year at an event every Boston Scientific employee is invited to be part of: Everyone Makes an Impact (EMAI).
EMAI is a regular reminder to our 48,000-plus employees of how they are helping physicians to transform the lives of the 37 million people our products reach each year.
Since the early 2000s, Boston Scientific has gathered employees at each of its major sites around the globe each year to celebrate and reinforce this shared purpose through EMAI events.
Structures and policies will always guide our quality system. But employees must feel personally connected to the patient experience. When they are engaged in the process and feel personally invested, a culture of quality can thrive.
Guiding our approach to quality is the Boston Scientific Best4 strategy, which revolves around four key metrics: agility, performance, compliance and, last but certainly not least, culture. That’s where EMAI comes in.
During EMAI, people who have benefitted from our medical devices share their moving stories live at our facilities in the U.S., Europe, Latin America and the Asia Pacific region. It’s an emotional and powerful reminder that all employees make a difference, regardless of what we do for the company.
EMAI events have evolved and grown over the years. What hasn’t changed is the recommitment to quality that employees make each year by signing the quality wall at their site.
Perhaps the people who best understand the meaning of EMAI are the employees who have gotten Boston Scientific devices themselves.
Esther Melvin is a sales training manager with the Interventional Oncology team. Her roles at Boston Scientific have included advising physicians on a technology called cryoablation. A few years ago, Esther was diagnosed with metastatic breast cancer, and faced terrible pain as the cancer spread to her bones. After considering numerous treatment options, she chose to undergo cryoablation.
Esther appeared at an EMAI event in 2022 to explain how crucial her colleagues are to the patients they serve.
“The quality of our products is so important because it can change a life,” Esther told them. “It changed mine.”
Our highest priority is to ensure that our products are safe and reliable. Read more about our approach to quality in our recently released 2023 Performance Report.
By Roz Burke, Senior Vice President, Global Quality and Regulatory
Sponsored by:
